Display options
Cite
Badiee P, Badali H, Diba K, et al. Susceptibility pattern of . Curr Med Mycol. 2016;2(1):24-29doi: 10.18869/acadpub.cmm.2.1.24.
Badiee, P., Badali, H., Diba, K., Ghadimi Moghadam, A., Hosseininasab, A., Jafarian, H., Mohammadi, R., Mirhendi, H., Najafzadeh, M. J., Shamsizadeh, A., & Soltani, J. (2016). Susceptibility pattern of . Current medical mycology, 2(1), 24-29. https://doi.org/10.18869/acadpub.cmm.2.1.24
Badiee, P, et al. "Susceptibility pattern of ." Current medical mycology vol. 2,1 (2016): 24-29. doi: https://doi.org/10.18869/acadpub.cmm.2.1.24
Badiee P, Badali H, Diba K, Ghadimi Moghadam A, Hosseininasab A, Jafarian H, Mohammadi R, Mirhendi H, Najafzadeh MJ, Shamsizadeh A, Soltani J. Susceptibility pattern of . Curr Med Mycol. 2016 Mar;2(1):24-29. doi: 10.18869/acadpub.cmm.2.1.24. PMID: 28681009; PMCID: PMC5490294.
Copy Download .nbib Format: NLM
Share it on

Curr Med Mycol. 2016 Mar;2(1):24-29. doi: 10.18869/acadpub.cmm.2.1.24.

Susceptibility pattern of .

Current medical mycology

P Badiee, H Badali, K Diba, A Ghadimi Moghadam, A Hosseininasab, H Jafarian, R Mohammadi, H Mirhendi, M J Najafzadeh, A Shamsizadeh, J Soltani

Affiliations

  1. Professor, Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  2. Department of Medical Mycology and Parasitology, Invasive Fungi Research Centre (IFRC), School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  3. Cellular and Molecular Research Center, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  4. Department of Pediatrics, Yasuj University of Medical Sciences, Yasuj, Iran.
  5. Department of Pediatrics, Kerman University of Medical Sciences, Kerman, Iran.
  6. Department of Medical Parasitology and Mycology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  7. Department of Medical Mycology and Parasitology, School of Public Health and Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran.
  8. Department of Parasitology and Mycology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  9. Jundishapur Infectious and Tropical Diseases Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  10. Department of Pediatrics, Besat Tertiary Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran.

PMID: 28681009 PMCID: PMC5490294 DOI: 10.18869/acadpub.cmm.2.1.24

Abstract

BACKGROUND AND PURPOSE: Candidiasis is a major fungal infection, and

MATERIALS AND METHODS: Clinical samples were cultured on Sabouraud dextrose agar and were incubated at room temperature for seven days. The isolates were transferred to Professor Alborzi Clinical Microbiology Research Center, Shiraz, Iran.

RESULTS: Overall, 397

CONCLUSION: According to our data, fluconazole is the drug of choice for management of patients at risk for systemic candidiasis throughout the region, since it is cost-effective with low side effects.

Keywords: Amphotericin B; Candida albicans; Candidiasis; Minimum inhibitory concentration

Conflict of interest statement

None declared.

References

  1. Bioinformation. 2014 Nov 27;10(11):667-70 - PubMed
  2. Expert Rev Anti Infect Ther. 2005 Aug;3(4):467-87 - PubMed
  3. Jundishapur J Microbiol. 2015 Sep 08;8(9):e28057 - PubMed
  4. Virulence. 2013 Feb 15;4(2):119-28 - PubMed
  5. J Clin Microbiol. 2012 Sep;50(9):2846-56 - PubMed
  6. Iran J Microbiol. 2011 Dec;3(4):183-8 - PubMed
  7. Lancet Infect Dis. 2002 Sep;2(9):550-63 - PubMed
  8. Eur J Intern Med. 2011 Dec;22(6):611-5 - PubMed
  9. Med Mycol. 2013 Aug;51(6):657-63 - PubMed
  10. Drugs. 2013 Jun;73(9):919-34 - PubMed
  11. Rev Soc Bras Med Trop. 2013 May-Jun;46(3):335-9 - PubMed
  12. East Mediterr Health J. 2011 May;17(5):425-30 - PubMed
  13. Clin Microbiol Infect. 2014 Jul;20(7):698-705 - PubMed
  14. J Antimicrob Chemother. 2005 Sep;56(3):532-7 - PubMed
  15. Jundishapur J Microbiol. 2014 Sep;7(9):e11858 - PubMed

Publication Types